LBA32 Tisotumab vedotin in previously treated recurrent or metastatic cervical cancer: Results from the phase II innovaTV 204/GOG-3023/ENGOT-cx6 study

Autor:	Bente Lund, F. Forget, Domenica Lorusso, Antonio González-Martín, Leonardo Viana Nicacio, Jeffrey R. Harris, Reshma A. Rangwala, M. Chen, Robert L. Coleman, Linn Woelber, David Cibula, M.S.L. Teng, Christine Gennigens, Ignace Vergote, Leslie M Randall, Bradley J. Monk, Sandro Pignata, Andrés Redondo, M. D. Smith, S.D. Vindeløv
Rok vydání:	2020
Předmět:	Oncology medicine.medical_specialty business.industry Internal medicine medicine Hematology Previously treated business Metastatic cervical cancer
Zdroj:	Annals of Oncology. 31:S1162-S1163
ISSN:	0923-7534
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::8133c09f6c53a366359dca423ac6f713 https://doi.org/10.1016/j.annonc.2020.08.2262 Zobrazit plný text záznamu